Muramoylpentapeptide Carboxypeptidase
"Muramoylpentapeptide Carboxypeptidase" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Enzyme which catalyzes the peptide cross-linking of nascent CELL WALL; PEPTIDOGLYCAN.
| Descriptor ID |
D002267
|
| MeSH Number(s) |
D08.811.277.656.350.245.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Muramoylpentapeptide Carboxypeptidase".
Below are MeSH descriptors whose meaning is more specific than "Muramoylpentapeptide Carboxypeptidase".
This graph shows the total number of publications written about "Muramoylpentapeptide Carboxypeptidase" by people in this website by year, and whether "Muramoylpentapeptide Carboxypeptidase" was a major or minor topic of these publications.
![]()
To see the data from this visualization as text,
click here.
Below are the most recent publications written about "Muramoylpentapeptide Carboxypeptidase" by people in Profiles.
-
Novel non-mecA-containing staphylococcal chromosomal cassette composite island containing pbp4 and tagF genes in a commensal staphylococcal species: a possible reservoir for antibiotic resistance islands in Staphylococcus aureus. Antimicrob Agents Chemother. 2004 May; 48(5):1823-36.
-
Transcriptional induction of the penicillin-binding protein 2 gene in Staphylococcus aureus by cell wall-active antibiotics oxacillin and vancomycin. Antimicrob Agents Chemother. 2003 Mar; 47(3):1028-36.
-
Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50. J Antimicrob Chemother. 1998 Aug; 42(2):199-209.
-
Increased production of penicillin-binding protein 2, increased detection of other penicillin-binding proteins, and decreased coagulase activity associated with glycopeptide resistance in Staphylococcus aureus. Antimicrob Agents Chemother. 1997 Aug; 41(8):1788-93.
-
Molecular correlation between in vitro and in vivo activity of beta-lactam and beta-lactamase inhibitor combinations against methicillin-resistant Staphylococcus aureus. J Lab Clin Med. 1995 Feb; 125(2):200-11.
-
Emergence of resistance to beta-lactam antibiotics in Pseudomonas aeruginosa during treatment with new beta-lactams. Chemioterapia. 1985 Feb; 4(1):95-101.